4 recruiting. 4 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Recruiting 4 |
| Phase 3 | 1 | Recruiting 1 |
Follow Death: new trials by email Literature Review of Death trials Research Report on Death
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Early Double Sequential Defibrillation in Out of Hospital Cardiac Arrest Double sequential defibirllation, Standard defibrillation - Out of Hospital Cardiac Arrest, Ventricular Fibrillation | Phase 2 / Phase 3 | Recruiting | Gabriel Riva | 916 | 2025-09-08 | 2026-02-17 |
| Targeted Therapy With Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Cardiomyopathy Tideglusib, Placebo - Arrhythmogenic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy | Phase 2 | Recruiting | Hamilton Health Sciences Corporation | 120 | 2025-03-21 | 2026-03-12 |
| Using Placental Pathology to Prevent Recurrent Adverse Pregnancy Outcomes: A Pilot Project Lovenox 40mg - Adverse Pregnancy Outcome | Phase 2 | Recruiting | Endeavor Health | 20 | 2023-12-26 | 2026-07-23 |
| Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT Hydroxyurea, Alemtuzumab, Fludarabine - Primary Immunodeficiency (PID), Congenital Bone Marrow Failure Syndromes | Phase 2 | Recruiting | Paul Szabolcs | 100 | 2014-02-04 | 2025-12-15 |
Abortion, Spontaneous (1) · Adrenoleukodystrophy (1) · Anemia, Diamond-Blackfan (1) · Anemia, Sickle Cell (1) · Arrhythmias, Cardiac (1) · Arrhythmogenic Right Ventricular Dysplasia (1) · Arthritis, Juvenile (1) · Autoimmune Lymphoproliferative Syndrome (1) · Chediak-Higashi Syndrome (1) · Congenital Bone Marrow Failure Syndromes (1) · Congenital amegakaryocytic thrombocytopenia (1) · Crohn Disease (1) · Death, Sudden (1) · Death, Sudden, Cardiac (1) · Dyskeratosis Congenita (1)
Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Cardiovascular Diseases (2) · Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Death, Sudden (2) · Heart Arrest (2) · Heart Diseases (2) · Adrenal Gland Diseases (1) · Adrenal Insufficiency (1) · Albinism (1) · Anemia (1) · Anemia, Aplastic (1) · Anemia, Hemolytic (1)
Alemtuzumab (1) · Enoxaparin (1) · Hydroxyurea (1) · Melphalan (1) · Thiotepa (1) · fludarabine (1) · fludarabine phosphate (1) · tideglusib (1)
Endeavor Health (1) · Gabriel Riva (1) · Hamilton Health Sciences Corporation (1) · Paul Szabolcs (1)
United States (2) · Canada (1) · Netherlands (1) · Spain (1) · Sweden (1)
Akil Awad, M.D. Ph.D. (1) · Andreas Claesson, R.N. Ph.D. (1) · Carl Magnusson, R.N., Ph.D. (1) · Gabriel Riva, M.D. Ph.D. (1) · Jason D Roberts, MD MAS (1) · Johan Israelsson, R.N. Ph.D. (1) · Paul Szabolcs, MD (1) · Sunitha Suresh (1)